FIELD: cell biology; medicine.
SUBSTANCE: present invention relates to cell biology, medicine, in particular to different compositions, which include an extracellular vesicle obtained from Lactobacillus paracasei as an active ingredient. Thus, the invention discloses pharmaceutical compositions for the prevention or relief of an inflammatory disease, for prevention or treatment of cancer, food compositions for the prevention or relief of cancer, for prevention or relief of an inflammatory disease, compositions for inhalation for the prevention or treatment of an inflammatory disease, for prevention or treatment of cancer, a cosmetic composition for the prevention or relief of an inflammatory disease. The invention also discloses methods for the treatment and use of a composition containing an extracellular vesicle obtained from Lactobacillus paracasei.
EFFECT: present invention allows for an increase in the efficiency of remedies for suppression of TNF-α expression.
26 cl, 21 dwg, 1 tbl, 7 ex
Title |
Year |
Author |
Number |
LACTOBACILLUS PARACASEI STRAIN AND ITS USE |
2019 |
- Ko, Kvan Pe
- Kim, Vunki
- Dzhan, Yu-Dzhin
- So, Boram
- Li, Dzhun-Chkhul
- Nam, Tkhe-Vuk
- Kim, Insu
- Li, Dzhin-Vu
|
RU2790297C2 |
NEW LACTIC ACID BACTERIA AND APPLICATION THEREOF |
2018 |
- Kim, Dong-Hyun
- Han, Myung Joo
|
RU2752157C2 |
NEW LACTOBACILLUS PLANTARUM STRAIN, COMPOSITIONS CONTAINING IT, AND RELATED METHOD AND ITS USE |
2018 |
- Kim, Dong-Hyun
- Han, Myung Joo
|
RU2790442C2 |
NANOVESICLES PRODUCED FROM BACTERIA OF THE GENUS SPHINGOMONAS AND APPLICATION THEREOF |
2019 |
|
RU2771781C1 |
COMPOSITION FOR PREVENTING OR TREATING NEUROLOGICAL OR MENTAL DISORDERS, CONTAINING EXTRACELLULAR VESICLES DERIVED FROM LACTOBACILLUS PARACASEI |
2021 |
|
RU2819806C1 |
COMPOSITIONS BASED ON CANNABIDIOL AND THEIR USE METHODS |
2017 |
|
RU2756773C2 |
FUNCTIONALIZED SACCHARIDES AS ANTI-INFLAMMATORY AGENTS |
2018 |
- Petkov, Spas
- Hautekiet, Veerle
|
RU2772214C2 |
DOUBLE-CHAINED OLIGONUCLEOTIDE SPECIFIC TO CTGF GENE AND COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF FIBROUS DISEASES AND DISEASES ASSOCIATED WITH RESPIRATORY SYSTEM |
2020 |
- Park, Han-Oh
- Kim, Tae-Rim
- Ko, Young-Ho
- Yun, Sung Il
- Park, Jun Hong
|
RU2807108C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ATTENUATED Streptococcus pneumoniae STRAINS, AND ITS APPLICATION |
2018 |
- Rhee, Dong-Kwon
- Seon, Seung-Han
- Kim, Bo-Gyung
|
RU2772131C2 |
USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY |
2017 |
- Rajnal, Sofi, N.
- Ode, Annik
- Ote, Valeri
- Sharon, Kristin
- Dyuran, Zhan-Deni
- Kergo, Mishlen
|
RU2806346C2 |